“Nevisense has mainly two advantages: Firstly: less need for cutting. Second advantage from my point of view is a nearly 100% hit rate.”Prof. Dr. Axel Hauschild, Kiel
"The number one advantage regarding Nevisense is that it backs up my decision and provides me with more certainty in whether or not to excise a lesion"Dr. Isabel Gahlen, Ludwigsburg, Germany
SciBase announces skin barrier testing collaboration with leading Swiss research centerDecember 6, 2018
Clinical Guideline for Nevisense published in GermanyNovember 19, 2018
The following people have been appointed as members of SciBase Holding’s election committee for the Annual General Meeting in 2019:November 5, 2018
- Load more news...